{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:48:18Z","timestamp":1790711298797,"version":"4.1.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00234","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T04:50:45Z","timestamp":1550551845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity"],"prefix":"10.3389","volume":"10","author":[{"given":"Getahun","family":"Abate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahreta","family":"Hamzabegovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Eickhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1164\/rccm.200808-1258ED","article-title":"The importance of nontuberculous mycobacterial lung disease","volume":"178","author":"Iseman","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1086\/648443","article-title":"Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology","volume":"49","author":"Cassidy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e91879","DOI":"10.1371\/journal.pone.0091879","article-title":"Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study","volume":"9","author":"Mirsaeidi","year":"2014","journal-title":"PLoS ONE"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1513\/AnnalsATS.201503-173OC","article-title":"The burden of pulmonary nontuberculous mycobacterial disease in the United States","volume":"12","author":"Strollo","year":"2015","journal-title":"Ann Am Thorac Soc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3978\/j.issn.2072-1439.2013.12.24","article-title":"Nontuberculous mycobacterial pulmonary infections","volume":"6","author":"Johnson","year":"2014","journal-title":"J Thorac Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12879-016-1521-3","article-title":"Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012","volume":"16","author":"Shah","year":"2016","journal-title":"BMC Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijmyco.2014.12.005","article-title":"Nontuberculous mycobacteria in Middle East: current situation and future challenges","volume":"4","author":"Velayati","year":"2015","journal-title":"Int J Mycobacteriol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1183\/09031936.00063514","article-title":"Mycobacterial diseases developed during anti-tumour necrosis factor-alpha therapy","volume":"44","author":"Yoo","year":"2014","journal-title":"Eur Respir J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/thoraxjnl-2014-206470","article-title":"Increased risk of mycobacterial infections associated with anti-rheumatic medications","volume":"70","author":"Brode","year":"2015","journal-title":"Thorax"},{"key":"B11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/tid.12170","article-title":"Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study","volume":"16","author":"Longworth","year":"2014","journal-title":"Transpl Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin Chest Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3201\/eid1907.120615","article-title":"Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009","volume":"19","author":"Seddon","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1128\/JCM.43.7.3150-3158.2005","article-title":"Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients","volume":"43","author":"Maekura","year":"2005","journal-title":"J Clin Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3201\/eid1903.120735","article-title":"Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011","volume":"19","author":"de","year":"2013","journal-title":"Emerg Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0954-6111(03)00120-3","article-title":"Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex","volume":"97","author":"Fujita","year":"2003","journal-title":"Respir Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1165\/rcmb.2015-0256RC","article-title":"A rhesus macaque model of pulmonary nontuberculous mycobacterial disease","volume":"54","author":"Winthrop","year":"2016","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0962-8479(94)90080-9","article-title":"Six years' experience with the discontinuation of BCG vaccination","volume":"75","author":"Trnka","year":"1994","journal-title":"Tuber Lung Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/infdis\/174.6.1212","article-title":"Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis","volume":"174","author":"Horsburgh","year":"1996","journal-title":"J Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tube.2017.05.001","article-title":"Pilot studies of a human BCG challenge model","volume":"105","author":"Blazevic","year":"2017","journal-title":"Tuberculosis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/infdis\/174.1.113","article-title":"Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guerin","volume":"174","author":"Kemp","year":"1996","journal-title":"J Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1128\/CVI.00394-14","article-title":"Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice","volume":"21","author":"Derrick","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.micinf.2013.09.006","article-title":"Investigations of TB vaccine-induced mucosal protection in mice","volume":"16","author":"Blazevic","year":"2014","journal-title":"Microbes Infect."},{"key":"B26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1128\/IAI.01262-15","article-title":"Mycobacterium-specific gamma9delta2 T cells mediate both pathogen-inhibitory and CD40 ligand-dependent antigen presentation effects important for tuberculosis immunity","volume":"84","author":"Abate","year":"2015","journal-title":"Infect Immun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1086\/444423","article-title":"Flow-cytometric detection of vaccinia-induced memory effector CD4+, CD8+, and gamma delta TCR+ T cells capable of antigen-specific expansion and effector functions","volume":"192","author":"Abate","year":"2005","journal-title":"J Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.1064571","article-title":"Priming of memory but not effector CD8 T cells by a killed bacterial vaccine","volume":"294","author":"Lauvau","year":"2001","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nature Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1003119","DOI":"10.1371\/journal.ppat.1003119","article-title":"Granzyme A produced by gamma(9)delta(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen","volume":"9","author":"Spencer","year":"2013","journal-title":"PLoS Pathog."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.4049\/jimmunol.181.7.4471","article-title":"Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity","volume":"181","author":"Spencer","year":"2008","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1128\/IAI.71.4.1763-1773.2003","article-title":"Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth","volume":"71","author":"Worku","year":"2003","journal-title":"Infect Immun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.vaccine.2008.11.079","article-title":"Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults","volume":"27","author":"Frey","year":"2009","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1473-3099(04)01130-2","article-title":"Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy","volume":"4","author":"Karakousis","year":"2004","journal-title":"Lancet Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3201\/eid1610.091201","article-title":"Changing epidemiology of pulmonary nontuberculous mycobacteria infections","volume":"16","author":"Thomson","year":"2010","journal-title":"Emerg Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1183\/09031936.98.11061227","article-title":"Analysis of BAL fluid in Mycobacterium avium-intracellulare infection in individuals without predisposing lung disease","volume":"11","author":"Yamazaki","year":"1998","journal-title":"Eur Respir J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1164\/ajrccm.160.6.9902019","article-title":"Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection","volume":"160","author":"Yamazaki","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1046\/j.1440-1711.2003.01193.x","article-title":"Apoptosis of CD4+ and CD8+ T cells during experimental infection with Mycobacterium avium is controlled by Fas\/FasL and Bcl-2-sensitive pathways, respectively","volume":"81","author":"Zhong","year":"2003","journal-title":"Immunol Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/clim.2001.5037","article-title":"Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages","volume":"99","author":"Roger","year":"2001","journal-title":"Clin Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1242\/bio.019315","article-title":"An in vitro model of granuloma-like cell aggregates substantiates early host immune responses against Mycobacterium massiliense infection","volume":"5","author":"Je","year":"2016","journal-title":"Biol Open"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1128\/CVI.00173-08","article-title":"Clinical and immunologic features of an atypical intracranial Mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections","volume":"15","author":"Sadek","year":"2008","journal-title":"Clin Vaccine Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e109941","DOI":"10.1371\/journal.pone.0109941","article-title":"Importance of reciprocal balance of T cell immunity in Mycobacterium abscessus complex lung disease","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/cei.12253","article-title":"Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease","volume":"176","author":"Kim","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/resp.12109","article-title":"Severe vitamin D deficiency is associated with non-tuberculous mycobacterial lung disease: a case-control study","volume":"18","author":"Jeon","year":"2013","journal-title":"Respirology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1086\/318087","article-title":"Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex","volume":"183","author":"Vankayalapati","year":"2001","journal-title":"J Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1128\/IAI.72.12.6884-6891.2004","article-title":"Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection","volume":"72","author":"Gilbertson","year":"2004","journal-title":"Infect Immun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1189\/jlb.1007696","article-title":"Animal model of Mycobacterium abscessus lung infection","volume":"83","author":"Ordway","year":"2008","journal-title":"J Leukocyte Biol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1128\/IAI.63.6.2282-2287.1995","article-title":"Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon","volume":"63","author":"Saunders","year":"1995","journal-title":"Infect Immun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1128\/IAI.73.5.2621-2627.2005","article-title":"CD4+ T cells but Not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route","volume":"73","author":"Petrofsky","year":"2005","journal-title":"Infect Immun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0119737","DOI":"10.1371\/journal.pone.0119737","article-title":"Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients","volume":"10","author":"Steindor","year":"2015","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1128\/IAI.00014-07","article-title":"Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL\/6 mice","volume":"75","author":"Rottman","year":"2007","journal-title":"Infect Immun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"7702","DOI":"10.4049\/jimmunol.179.11.7702","article-title":"Characterization of the deregulated immune activation occurring at late stages of mycobacterial infection in TNF-deficient mice","volume":"179","author":"Florido","year":"2007","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1046\/j.1365-2567.2001.01237.x","article-title":"Interleukin-12 primes CD4+ T cells for interferon-gamma production and protective immunity during Mycobacterium avium infection","volume":"103","author":"Silva","year":"2001","journal-title":"Immunology"},{"key":"B55","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1128\/IAI.65.7.2792-2802.1997","article-title":"The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin","volume":"65","author":"Frehel","year":"1997","journal-title":"Infect Immun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1128\/IAI.68.10.5824-5829.2000","article-title":"Interaction of Mycobacterium avium with human monocyte-derived dendritic cells","volume":"68","author":"Mohagheghpour","year":"2000","journal-title":"Infect Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e3012","DOI":"10.1038\/cddis.2017.420","article-title":"Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D","volume":"8","author":"Whang","year":"2017","journal-title":"Cell Death Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"160185","DOI":"10.1098\/rsob.160185","article-title":"The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages","volume":"6","author":"Roux","year":"2016","journal-title":"Open Biol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.micpath.2010.12.004","article-title":"Mycobacterium avium uses apoptotic macrophages as tools for spreading","volume":"50","author":"Early","year":"2011","journal-title":"Microb. Pathog."},{"key":"B60","doi-asserted-by":"publisher","first-page":"E943","DOI":"10.1073\/pnas.1321390111","article-title":"Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation","volume":"111","author":"Bernut","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B61","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1189\/jlb.71.1.80","article-title":"Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo","volume":"71","author":"Wagner","year":"2002","journal-title":"J Leukocyte Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1189\/jlb.0306206","article-title":"Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages","volume":"80","author":"Vazquez","year":"2006","journal-title":"J Leukocyte Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1128\/CVI.00427-13","article-title":"Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG","volume":"20","author":"Fletcher","year":"2013","journal-title":"Clin Vaccine Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-0033-1333573","article-title":"Underlying host risk factors for nontuberculous mycobacterial lung disease","volume":"34","author":"Chan","year":"2013","journal-title":"Semin Respir Crit Care Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T02:56:39Z","timestamp":1606532199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2019.00234"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00234","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"article-number":"234"}}